TherapeuticsMD TXMD
NASDAQ TXMD
$1.74 +0.06 (+3.57%)
At close: Nov 10, 2026 · 4:00 PM EST

TherapeuticsMD (TXMD) Notes Payables (2009 - 2012)

Updated

Analysis

TherapeuticsMD (TXMD) Notes Payables (2009 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 TherapeuticsMD 20.14 Mn -12.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 2.10 Mn
Jun 30, 2012 299,220.00
Mar 31, 2012 1.35 Mn
Dec 31, 2011 200,000.00
Sep 30, 2011 365,000.00
Jun 30, 2011 99,000.00
Mar 31, 2011 239,000.00
Dec 31, 2010 543,531.00
Mar 31, 2010 800,000.00
Dec 31, 2009 175,138.00
Sep 30, 2009 300,000.00
API Access

TherapeuticsMD Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TXMD&period=max&api_key=YOUR_API_KEY